BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1288822)

  • 21. Prevalence of Trichomonas vaginalis infection in and around Surat.
    Chakraborty T; Mulla SA; Kosambiya JK; Desai VK
    Indian J Pathol Microbiol; 2005 Oct; 48(4):542-5. PubMed ID: 16366122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis.
    Brown HL; Fuller DD; Jasper LT; Davis TE; Wright JD
    Infect Dis Obstet Gynecol; 2004; 12(1):17-21. PubMed ID: 15460191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of the Papanicolaou smear in the diagnosis of asymptomatic infection with Trichomonas vaginalis.
    Weinberger MW; Harger JH
    Obstet Gynecol; 1993 Sep; 82(3):425-9. PubMed ID: 8355946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of trichomoniasis by polymerase chain reaction.
    Ryu JS; Chung HL; Min DY; Cho YH; Ro YS; Kim SR
    Yonsei Med J; 1999 Feb; 40(1):56-60. PubMed ID: 10198607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative evaluation of the Papanicolaou test for the diagnosis of trichomoniasis.
    Lobo TT; Feijó G; Carvalho SE; Costa PL; Chagas C; Xavier J; Simoes-Barbosa A
    Sex Transm Dis; 2003 Sep; 30(9):694-9. PubMed ID: 12972792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of Trichomonas vaginalis infection in symptomatic and asymptomatic women in Central Vietnam.
    Ton Nu PA; Nguyen VQ; Cao NT; Dessì D; Rappelli P; Fiori PL
    J Infect Dev Ctries; 2015 Jul; 9(6):655-60. PubMed ID: 26142677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary studies on target antigens for the diagnosis of Trichomonas vaginalis infection.
    Deng HY; Lee JC; Chou SC; Wang GR
    J Microbiol Immunol Infect; 1999 Mar; 32(1):14-20. PubMed ID: 11561565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of Gardnerella vaginalis, Trichomonas vaginalis and Candida albicans in the cytology clinic at Ibadan, Nigeria.
    Konje JC; Otolorin EO; Ogunniyi JO; Obisesan KA; Ladipo OA
    Afr J Med Med Sci; 1991 Mar; 20(1):29-34. PubMed ID: 1905467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Frequency of vaginal trichomoniasis and candidiasis and its relation to the clinical profile].
    Sánchez-Vega JT; Tay-Zavala J; Ruiz-Sánchez D; Ruiz-Hernández A; Robert-Guerrero L; Fernández-Presas AM; Martínez S
    Rev Latinoam Microbiol; 1993; 35(2):211-6. PubMed ID: 8209117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Trichomonas vaginalis and risk factors in women treated at public health units in Brazil: a transversal study.
    Grama DF; Casarotti Lda S; Morato MG; Silva LS; Mendonça DF; Limongi JE; Viana Jda C; Cury MC
    Trans R Soc Trop Med Hyg; 2013 Sep; 107(9):584-91. PubMed ID: 23880884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens.
    Huppert JS; Batteiger BE; Braslins P; Feldman JA; Hobbs MM; Sankey HZ; Sena AC; Wendel KA
    J Clin Microbiol; 2005 Feb; 43(2):684-7. PubMed ID: 15695664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of native microscopic examination of the vaginal flora in the diagnosis of trichomoniasis].
    Unzeitig V; Cupr Z; Bucek R
    Bratisl Lek Listy; 1989 Aug; 90(8):608-13. PubMed ID: 2691022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a latex agglutination test for the identification of Candida species in vaginal discharge.
    Reed BD; Pierson CL
    J Am Board Fam Pract; 1992; 5(4):375-80. PubMed ID: 1496893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of the Affirm VP-III using residual vaginal discharge collected from the speculum to characterize vaginitis in symptomatic women.
    Mulhem E; Boyanton BL; Robinson-Dunn B; Ebert C; Dzebo R
    J Low Genit Tract Dis; 2014 Oct; 18(4):344-6. PubMed ID: 24832170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relation between trichomoniasis and contraceptive methods].
    Sönmez Tamer G; Keçeli Ozcan S; Yücesoy G; Gacar G
    Turkiye Parazitol Derg; 2009; 33(4):266-9. PubMed ID: 20101574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of rapid immunochromatographic assay in the diagnosis of Trichomoniasis vaginalis.
    Hegazy MM; El-Tantawy NL; Soliman MM; El-Sadeek ES; El-Nagar HS
    Diagn Microbiol Infect Dis; 2012 Sep; 74(1):49-53. PubMed ID: 22727836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of an agglutination method of latex particles sensitized for the detection of vaginal candidiasis].
    Cabronero MC; Campos E; Picazo JJ; Romero J
    Med Clin (Barc); 1990 Mar; 94(9):329-32. PubMed ID: 2329867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and laboratory evidence of Trichomonas vaginalis infection among women of reproductive age in rural area.
    Fule SR; Fule RP; Tankhiwale NS
    Indian J Med Microbiol; 2012; 30(3):314-6. PubMed ID: 22885198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of vaginal mycosis and trichomoniasis. Reliability of cytologic smear, wet smear and culture.
    McLennan MT; Smith JM; McLennan CE
    Obstet Gynecol; 1972 Aug; 40(2):231-4. PubMed ID: 4558651
    [No Abstract]   [Full Text] [Related]  

  • 40. [Statistical evaluation and diagnostic consideration on trichomoniasis and candidiasis in vaginal pathology].
    Perini M; Rota G
    Quad Sclavo Diagn; 1983 Mar; 19(1):38-46. PubMed ID: 6675046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.